Other studies have revealed reduced invasiveness capacity of estrogen receptor‐negative breast cancer cells,28 altered colorectal cancer cell proliferation under a serum‐depleted condition,17 and even suppressed cellular growth in head and neck squamous cell and non‐small cell lung carcinomas after inhibiting RRM2.29 This evidence concerns the gene RRM2 and colorectal cancer.